Articles from Filana Therapeutics, Inc.

Working to advance TSC-related epilepsy program, with a focus on capital efficiency

New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating TSC-related epilepsy